Medical News

RSS

New LED device may help advance photodynamic therapy for skin cancer

Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They're exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating cancer called photodynamic therapy (PDT) -- work that they will describe at the Optical Society's (OSA) 94th annual meeting, Frontiers in Optics (FiO) 2010 at the Rochester Riverside Convention Center in Rochester, N.Y., from Oct. 24-28.

19 Oct 2010

JPO issues patent grant for Apricus's Femprox

Apricus Biosciences, Inc., backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Japanese Patent Office has issued a Decision to Grant a Patent for the Company's application on Femprox entitled, Compositions and Methods for Amelioration of Human Female Sexual Dysfunction.

19 Oct 2010

Type 2 diabetes and insulin use associated with CRC risk in men, but not women

There is an association between type 2 diabetes mellitus and colorectal cancer (CRC) among men, but not women, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

19 Oct 2010

New clinical trial to treat brain cancer launched

Cancer Research UK and Cancer Research Technology the charity's development and commercialisation arm together with immatics biotechnologies have launched the first clinical trial of a promising cancer vaccine to treat glioblastoma, one of the most common forms of brain cancer.

19 Oct 2010

Study assesses children's exposure to anesthesia and risk for developmental, behavioral disorders

When children undergo anesthesia during surgery, the long-term effects that anesthetics have on the developing brain is relatively unknown. A study presented at this year's American Society of Anesthesiologists Annual Meeting assesses the association between exposure to anesthesia in children 3 years old and younger and their risk for developmental and behavioral disorders.

19 Oct 2010

CoAxia presents SENTIS clinical trial for ischemic stroke at 2010 Congress in Seoul

CoAxia Inc. of Maple Grove, MN, announced today that the results of the SENTIS clinical trial a worldwide, multi-center, randomized study of its NeuroFlo catheter were presented on Saturday, October 16th, by SENTIS Principal Investigator, Professor Ashfaq Shuaib at the 2010 World Stroke Congress in Seoul, South Korea.

19 Oct 2010

New motion management software enables clear visualization of moving tumors in lung cancer

A 67-year-old female patient with lung cancer presented physicians with a difficult challenge: her tumor was small and it rode up and down with her breathing. During her treatment set up, all doctors saw on their therapy system's imaging equipment was a blur of motion. Fortunately, Leeds Teaching Hospitals NHS Trust was able to utilize its Symmetry motion management software; new imaging technology from Elekta that enables clear visualization of moving targets.

From Elekta 19 Oct 2010

OncoGenex announces public offering of common stock

OncoGenex Pharmaceuticals, Inc. today announced that it is commencing a public offering of its common stock and warrants to purchase shares of its common stock.

19 Oct 2010

biOasis receives final report on Collaborative Research project from UBC

biOasis Technologies Inc. has received a final report detailing results achieved within the Collaborative Research project with The University of British Columbia (UBC) that was announced by the Company on June 2, 2009.

19 Oct 2010

DOJ targets Blue Cross Blue Shield of Michigan in anti-trust violation

The Wall Street Journal/Dow Jones Newswires: "The U.S. Justice Department on Monday filed an antitrust lawsuit against Blue Cross Blue Shield of Michigan, alleging that provisions of its agreements with hospitals are anticompetitive." The action, filed in a Michigan federal court, challenges the "insurer's use of provisions known as 'most favored nation clauses'" (Kendall, 10/18).

19 Oct 2010

Althea installs INOVA H3-5 high-speed syringe filling line

Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.

19 Oct 2010

Halt Medical's Tulip RFVTA probe granted Canadian approval for treatment of uterine fibroids

Halt Medical, Inc. announced today that it has been approved to market the Tulip™ Radiofrequency Volumetric Thermal Ablation (RFVTA) probe in Canada. "The license we just received from Health Canada brings us an important step closer to our goal of making our uterine sparing procedure available to the millions of women in North America who suffer with uterine fibroids", said Russ DeLonzor, President and COO of Halt Medical.

19 Oct 2010

Study finds link between blood sugar levels and mortality risk in diabetic patients after non-cardiac surgeries

A clinical study presented at ANESTHESIOLOGY 2010 discovered that diabetics who presented for non-cardiac surgery with near normal blood sugar levels were at increased risk of death, as compared with their non-diabetic counterparts.

19 Oct 2010

Genetic variations linked to early menopause: Study

In a new study scientists have found that particular genetic variations are linked to early menopause before the age of 45. They compared the DNA of more than 2,000 women who had experienced early menopause with that of women who had menopause later than 45 years.

19 Oct 2010

Vitamin B12 may help protect against Alzheimer's disease

A new study shows that vitamin B12 may protect against Alzheimer's disease, adding more evidence to the scientific debate about whether the vitamin is effective in reducing the risk of memory loss. The research will be published in the October 19, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Oct 2010

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Having an egg allergy is not a reason to avoid getting the 2010-2011 flu vaccination.

19 Oct 2010

Study indicates vitamin D deficiency may increase lung transplant rejection

Vitamin D deficiency is associated with a significant increase in lung transplant rejection, according to research conducted at Loyola University Health System (LUHS). These data were presented Monday at The American Society for Bone and Mineral Research 2010 annual meeting in Toronto, Ontario.

19 Oct 2010

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

Findings from the PRECiSE 3 (P3) open label extension study for Cimzia, demonstrating the longest continuously running maintenance trial for an anti-TNF in Crohn's disease, will be exhibited at the 2010 Annual Scientific Meeting of the American College of Gastroenterology (ACG), taking place in San Antonio from October 15 – 20. Additionally, long-term efficacy data from the PRECiSE 4 (P4) clinical trial also will be presented at the meeting.

19 Oct 2010

Elorac acquires world-wide rights to Cidoxepin

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, is pleased to announce that it has acquired world-wide rights to the active agent Cidoxepin from Gideon Pharmaceuticals. Cidoxepin is the cis-isomer of the widely prescribed tricyclic compound doxepin.

19 Oct 2010

Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the website of the U.S. Food and Drug Administration (FDA) indicates that an Abbreviated New Drug Application (ANDA) for a generic version of Silenor® (doxepin) 3 mg and 6 mg was submitted on September 16, 2010.

19 Oct 2010

Medical News

New LED device may help advance photodynamic therapy for skin cancer

JPO issues patent grant for Apricus's Femprox

Type 2 diabetes and insulin use associated with CRC risk in men, but not women

New clinical trial to treat brain cancer launched

Study assesses children's exposure to anesthesia and risk for developmental, behavioral disorders

CoAxia presents SENTIS clinical trial for ischemic stroke at 2010 Congress in Seoul

New motion management software enables clear visualization of moving tumors in lung cancer

OncoGenex announces public offering of common stock

biOasis receives final report on Collaborative Research project from UBC

DOJ targets Blue Cross Blue Shield of Michigan in anti-trust violation

Althea installs INOVA H3-5 high-speed syringe filling line

Halt Medical's Tulip RFVTA probe granted Canadian approval for treatment of uterine fibroids

Study finds link between blood sugar levels and mortality risk in diabetic patients after non-cardiac surgeries

Genetic variations linked to early menopause: Study

Vitamin B12 may help protect against Alzheimer's disease

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Study indicates vitamin D deficiency may increase lung transplant rejection

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

Elorac acquires world-wide rights to Cidoxepin

Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News